R.I. invested in Amgen’s success

Amgen Inc., Rhode Island’s largest biotechnology employer, is in a race to develop a new anti-cholesterol drug. And as a story on Page 18 explains, the state has more than a rooting interest. In 2005, the company had 1,300 employees and was the state’s fifth-largest manufacturer. By 2010 the company was down to 900 workers

Already a Subscriber? Log in

To Continue Reading This Article

Become a Providence Business News subscriber and get immediate access to all of our premier content and much more.

Learn More and Become a Subscriber

No posts to display